Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | IDH1 | O75874 | 13/20 | 0.65 |
| ▸ | CDK1 | P06493 | 2/20 | 0.64 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.64 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.64 |
| ▸ | CDK2 | P24941 | 2/20 | 0.64 |
| ▸ | CDK7 | P50613 | 2/20 | 0.64 |
| ▸ | CCNH | P51946 | 2/20 | 0.64 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.64 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.64 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | CCND1 | P24385 | 1/20 | 0.63 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.63 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28175993 | 0.83 | CYP1A2 (0.64) | CYP1A2CYP3A4MAPTMAPK1CYP2C19 | |
| SCHEMBL27176707 | 0.83 | CDK1 (0.63) | CYP1A2CYP3A4MAPTMAPK1CYP2C19 | |
| SCHEMBL23447678 | 0.82 | IDH1 (0.67) | MAPTIDH1 | |
| SCHEMBL7570746 | 0.81 | MCL1 (0.64) | IDH1MCL1 | |
| SCHEMBL26657377 | 0.81 | RXFP1 (0.66) | MAPTIDH1THRB | |
| SCHEMBL3697796 | 0.80 | MEN1 (0.60) | CYP3A4MAPTCYP2C19IDH1 | |
| SCHEMBL1892651 | 0.80 | CYP1A2 (1.00) | CYP1A2CYP3A4MAPTMAPK1CYP2C19 | |
| SCHEMBL29493742 | 0.80 | CYP1A2 (1.00) | CYP1A2CYP3A4MAPTMAPK1CYP2C19 | |
| SCHEMBL26656980 | 0.80 | IDH1 (0.73) | IDH1THRB | |
| SCHEMBL26657708 | 0.79 | IDH1 (0.64) | IDH1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120094964-A1 | SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS | RAQUALIA PHARMA INC. (JP) | 2012-04-19 | — | — | US | disclosed |
| EP-2424517-A1 | SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS | RaQualia Pharma Inc (JP) | 2012-03-07 | — | — | EP | disclosed |
| WO-2010125831-A1 | SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS | RAQUALIA PHARMA INC. (JP) | 2010-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120094964-A1 | SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS | TRPM8, TRPM5, TRPM6 | CYP1A2 2926/4885CYP3A4 3018/4885MAPT 2242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.